Medicare Enrolled
Dr. Douglas Mund, M.D.
Rheumatology · New Hyde Park, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mund from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mund?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mund
Dr. Douglas Mund is a rheumatology specialist in New Hyde Park, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Mund performed 30,389 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mund received a total of $8,373 from 36 pharmaceutical and/or device companies across 529 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mund is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 10% volume in NY
$8,373 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗30,389
Medicare services
Top 10% in NY for rheumatology
Not available
Unique patients (not deduplicated)
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 17,160 | $18 | $87 |
| Romosozumab injection (Evenity) for osteoporosis | 7,980 | $8 | $39 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,138 | $110 | $416 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
831 | $1 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
392 | $8 | $32 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $77 | $288 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
380 | $12 | $64 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
290 | $10 | $43 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
272 | $3 | $10 |
| High-sensitivity C-reactive protein test A blood test that measures high-sensitivity C-reactive protein to detect infection or inflammation. |
269 | $13 | $49 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
242 | $8 | $33 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
215 | $70 | $480 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
136 | $60 | $335 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $145 | $587 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
113 | $29 | $113 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
80 | $6 | $42 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
78 | $101 | $492 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
76 | $4 | $19 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
47 | $16 | $75 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
37 | $2 | $10 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
29 | $6 | $29 |
| Rheumatoid factor level | 28 | $5 | $30 |
| New patient office visit, complex (60-74 min) | 28 | $191 | $746 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
25 | $9 | $44 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $150 | $544 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
17 | $13 | $63 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.6% high complexity
87.9% medium
11.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,373
Total received (2018-2024)
Avg $1,196/year across 7 years
Top 32% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
529
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,214
2023
$1,171
2022
$2,007
2021
$797
2020
$267
2019
$1,533
2018
$1,384
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$402
ABBVIE INC.
$382
PFIZER INC.
$183
Ferring Pharmaceuticals Inc.
$69
Amgen Inc.
$53
GlaxoSmithKline, LLC.
$31
Mannkind Corporation
$24
Aurinia Pharma U.S., Inc.
$21
Lilly USA, LLC
$19
E.R. Squibb & Sons, L.L.C.
$16
Exact Sciences Corporation
$15
Top 3 companies account for 79.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,044
PFIZER INC.
$1,161
ABBVIE INC.
$1,134
Horizon Therapeutics plc
$848
AbbVie, Inc.
$647
Amgen Inc.
$495
AbbVie Inc.
$268
Janssen Biotech, Inc.
$248
Aurinia Pharma U.S., Inc.
$192
GlaxoSmithKline, LLC.
$163
Horizon Pharma plc
$138
Novo Nordisk Inc
$121
Janssen Pharmaceuticals, Inc
$119
Ferring Pharmaceuticals Inc.
$97
Abbott Laboratories
$70
Mallinckrodt Hospital Products Inc.
$69
AstraZeneca Pharmaceuticals LP
$58
Merck Sharp & Dohme LLC
$52
Cumberland Pharmaceuticals, Inc.
$48
Lilly USA, LLC
$48
Insulet Corporation
$45
Xeris Pharmaceuticals, Inc.
$40
Amarin Pharma Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Ultragenyx Pharmaceutical Inc.
$24
Mannkind Corporation
$24
Amneal Pharmaceuticals LLC
$23
Regeneron Healthcare Solutions, Inc.
$20
Amryt Pharma Holdings Ltd
$19
SANOFI PASTEUR INC.
$17
E.R. Squibb & Sons, L.L.C.
$16
Dexcom, Inc.
$16
Exact Sciences Corporation
$15
Merck Sharp & Dohme Corporation
$15
Esperion Therapeutics, Inc.
$14
Boston Scientific Corporation
$12
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFREZZA · Aimovig · BENLYSTA · COSENTYX · CRYSViTA · Cologuard Collection Kit · DUPIXENT · Dexcom G6 Transmitter · EUFLEXXA · EVENITY · FLUZONE QUADRIVALENT · FreeStyle Libre · FreeStyle Libre 2 · GARDASIL 9 · GVOKE HYPOPEN · GVOKE PFS · HUMIRA · Humira · KRYSTEXXA · LUPKYNIS · MOUNJARO · MYCAPSSA · NEXLETOL · ORENCIA · Omnipod · Ozempic · PENNSAID · PNEUMOVAX 23 · PREVNAR 20 · Prolia · RAYOS · REDITREX · RINVOQ · Rinvoq · Rybelsus · SAPHNELO · SIMPONI ARIA · SKYRIZI · STIOLTO RESPIMAT · Saxenda · TREMFYA · UNITHROID · Vascepa · WATCHMAN · XARELTO · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
354
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mund is a mixed practice specialist, with above-average Medicare volume (top 10% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mund experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Mund performed 17,160 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mund receive payments from pharmaceutical companies?
Yes. Dr. Mund received a total of $8,373 from 36 companies across 529 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mund's costs compare to other rheumatologists in New Hyde Park?
Dr. Mund's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mund) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in New Hyde Park
Browse rheumatologists in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology